Navigation Links
Neurocrine Biosciences to Present at the 8th Annual Needham Life Sciences Conference
Date:6/4/2009

LIVE AUDIO WEBCAST WEDNESDAY, JUNE 10, 2009

SAN DIEGO, June 4 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences will be presenting at the 8th Annual Needham Life Sciences Conference in New York.

The live presentation takes place Wednesday, June 10, 2009 at 1:30 p.m. Eastern Time (ET)/10:30 a.m. Pacific Time (PT). The presentation will be simultaneously webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

About Neurocrine

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH), irritable bowel syndrome (IBS) and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Neurocrine Biosciences to Present at the Deutsche Bank 34th Annual Health Care Conference
2. Neurocrine Biosciences Reports First Quarter 2009 Results
3. Neurocrine Announces Work Force Restructuring
4. Neurocrine Biosciences to Present at the 16th Annual Future Leaders in the Biotech Industry Conference
5. Neurocrine Biosciences to Present at the Cowen and Company 29th Annual Health Care Conference
6. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2008 Financial Results
7. Neurocrine Biosciences to Present at the 20th Annual Piper Jaffray Health Care Conference
8. Neurocrine Biosciences Reports Third Quarter 2008 Results
9. Webcast Alert: Neurocrine Announces 3Q 08 Financial Results
10. Neurocrine Biosciences to Present at the Oppenheimer 19th Annual Healthcare Conference
11. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... PARK, CA (PRWEB) , ... March 30, 2017 ... ... cell (CTC) capture systems, will present four posters at the American Association ... presented at AACR demonstrate the ability of Vortex’s technology to rapidly collect highly ...
(Date:3/30/2017)... DUBLIN , March 30, 2017  Jazz Pharmaceuticals ... it has entered into license agreements with Nippon Shinyaku, ... Vyxeos ™ (cytarabine and daunorubicin liposome injection), or ... Under the terms of the agreements, Nippon Shinyaku will ... Vyxeos in Japan in return ...
(Date:3/30/2017)... Personal Genome Diagnostics Inc. (PGDx) today announced that ... for Cancer Research (AACR) Annual Meeting 2017, being held April ... company also announced that five scientists associated with PGDx—two co-founders ... Annual AACR Team Science Award. ... Doug Ward , CEO of ...
(Date:3/29/2017)... Washington, PA (PRWEB) , ... March 29, 2017 ... ... largest non-profit, voluntary, health organization dedicated to finding cures for inflammatory bowel diseases ... healthcare professionals, have partnered to deliver exclusive content to ReachMD learners. , ...
Breaking Biology Technology:
(Date:2/22/2017)... Feb. 22, 2017 With the biometrics ... Research identifies four technologies that innovative and agile ... significant share in the changing competitive landscape: multifactor ... authentication.   "Companies can no longer ... security," says Dimitrios Pavlakis , Industry Analyst ...
(Date:2/16/2017)... Feb. 16, 2017  Genos, a community for ... it has received Laboratory Accreditation from the College ... presented to laboratories that meet stringent requirements around ... rigorous processes. "Genos is committed to ... practices. We,re honored to be receiving CAP accreditation," ...
(Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
Breaking Biology News(10 mins):